Inhibitory effects of ethaverine, a homologue of papaverine, on monoamine oxidase activity in mouse brain

被引:8
作者
Lee, SS
Lee, JJ
Cheong, MJ
Kim, YH
Kim, Y
Yun, YP
Lee, CK
Lee, MK
机构
[1] Chungbuk Natl Univ, Coll Pharm, Heungduk Ku 361763, Cheongju, South Korea
[2] Chungnam Natl Univ, Coll Pharm, Taejon 305764, South Korea
关键词
ethaverine; papaverine; laudanosine; tetrahydropapaverine; kynuramine; monoamine oxidase;
D O I
10.1248/bpb.24.838
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of benzylisoquinoline compounds such as ethaverine, laudanosine, and tetrahydropapaverine on monoamine oxidase (MAO, EC 1.4.3.4) activity in mouse brain were investigated, Ethaverine show ed an inhibition of MAO activity in a concentration-dependent manner (57.6% inhibition at 40 muM). Papaverine also inhibited MAO activity (38.1% inhibition at 40 muM). However, laudanosine and tetrahydropapaverine did not inhibit MAO activity. The IC50 value of ethaverine for MAO was 25.5 muM. Ethaverine non-competitively inhibited MAO activity with a substrate kynuramine. The K-i value for ethaverine was 11.9 muM. In addition, ethaverine proved to preferentially inhibit type B MAO activity in a concentration-dependent manner, with an IC50 value of 32.8 muM. These results suggest that ethaverine partially contributes to the regulation of catecholamine content.
引用
收藏
页码:838 / 840
页数:3
相关论文
共 20 条
[1]   INHIBITION OF MONOAMINE OXIDASE-A AND MONOAMINE OXIDASE-B BY SIMPLE ISOQUINOLINE ALKALOIDS - RACEMIC AND OPTICALLY-ACTIVE 1,2,3,4-TETRAHYDRO-ISOQUINOLINE, 3,4-DIHYDRO-ISOQUINOLINE, AND FULLY AROMATIC ISOQUINOLINE [J].
BEMBENEK, ME ;
ABELL, CW ;
CHRISEY, LA ;
ROZWADOWSKA, MD ;
GESSNER, W ;
BROSSI, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (01) :147-152
[2]  
BENEDETTI MS, 1987, J NEURAL TRANSM, P103
[3]  
DENIKER P, 1984, SEARCH NEW ANTIDEPRE, P3
[4]   INVIVO AND INVITRO STUDIES ON EFFECT OF TETRAHYDROPAPAVEROLINE AND SALSOLINOL ON COMT AND MAO ACTIVITY IN RAT-BRAIN [J].
GIOVINE, A ;
RENIS, M ;
BERTOLINO, A .
PHARMACOLOGY, 1976, 14 (01) :86-94
[5]   HETEROGENEITY OF BIOCHEMICAL ACTIONS AMONG VASODILATORS [J].
GREENSLADE, FC ;
SCOTT, CK ;
NEWQUIST, KL ;
KRIDER, KM ;
CHASIN, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (01) :94-100
[6]  
KRAML M, 1965, BIOCHEM PHARMACOL, V14, P1684
[7]  
Lee SS, 1999, MED SCI RES, V27, P71
[8]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[9]   5-[4-(BENZYLOXY)PHENYL]-1,3,4-OXADIAZOL-2(3H)-ONE DERIVATIVES AND RELATED ANALOGS - NEW REVERSIBLE, HIGHLY POTENT, AND SELECTIVE MONOAMINE-OXIDASE TYPE-B INHIBITORS [J].
MAZOUZ, F ;
GUEDDARI, S ;
BURSTEIN, C ;
MANSUY, D ;
MILCENT, R .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (09) :1157-1167
[10]   4-(O-BENZYLPHENOXY)-N-METHYLBUTYLAMINE (BIFEMELANE) AND OTHER 4-(O-BENZYLPHENOXY)-N-METHYLALKYLAMINES AS NEW INHIBITORS OF TYPE-A AND TYPE-B MONOAMINE-OXIDASE [J].
NAOI, M ;
NOMURA, Y ;
ISHIKI, R ;
SUZUKI, H ;
NAGATSU, T .
JOURNAL OF NEUROCHEMISTRY, 1988, 50 (01) :243-247